Alterations in placental pendrin expression in pre-eclampsia
dc.contributor.author | Karataş, Ahmet | |
dc.contributor.author | Erdem, Havva | |
dc.contributor.author | Albayrak, Mustafa | |
dc.contributor.author | Oktay, Murat | |
dc.contributor.author | Özlü, Tülay | |
dc.contributor.author | Çakmak, Bülent | |
dc.contributor.author | Dönmez, Melahat Emine | |
dc.date.accessioned | 2020-04-30T22:39:05Z | |
dc.date.available | 2020-04-30T22:39:05Z | |
dc.date.issued | 2014 | |
dc.department | DÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü | en_US |
dc.description | oktay, murat/0000-0002-0893-4444; | en_US |
dc.description | WOS: 000333583100007 | en_US |
dc.description | PubMed: 23941406 | en_US |
dc.description.abstract | Introduction: Pendrin is an integral membrane protein and plays a key role in extracellular fluid volume and blood pressure control. We aimed to investigate the relationship between pendrin immunostaining intensity in normal and pre-eclamptic placental tissue. Methods: Fifty-six placental tissues, of which 26 were in pre-eclamptic, and 30 were in control group were evaluated by immunohistochemical staining. Positive immunostaining was evaluated using a semiquantitative score: 0, negative; +, mild; ++, moderate; and +++, intense. Results: There was more positive immunstaining in the pre-eclamptic placenta compared to the controls (p<0.001). A significant positive correlation was observed between immunostaining level and diastolic blood pressure (r = 0.533, p = 0.005) in the pre-eclamptic group. However, no significant correlation was observed between any condition and immunostaining level in the control group. Conclusions: Placentas in the pre-eclamptic group were significantly more immunostained with pendrin than were those in the control group. In addition, a positive correlation between immunostaining intensity with pendrin and both systolic and diastolic blood pressure were observed. Pendrin may play a role in the mechanism of severe hypertension in women with pre-eclampsia. | en_US |
dc.identifier.doi | 10.3109/14767058.2013.833600 | en_US |
dc.identifier.endpage | 690 | en_US |
dc.identifier.issn | 1476-7058 | |
dc.identifier.issn | 1476-4954 | |
dc.identifier.issue | 7 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 687 | en_US |
dc.identifier.uri | https://doi.org/10.3109/14767058.2013.833600 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12684/2591 | |
dc.identifier.volume | 27 | en_US |
dc.identifier.wos | WOS:000333583100007 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Informa Healthcare | en_US |
dc.relation.ispartof | Journal Of Maternal-Fetal & Neonatal Medicine | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Pendrin | en_US |
dc.subject | placenta | en_US |
dc.subject | pre-eclampsia | en_US |
dc.title | Alterations in placental pendrin expression in pre-eclampsia | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- 2591.pdf
- Boyut:
- 1 MB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text